Marty Tenenbaum, PhD

Marty Tenenbaum, PhD, is an advisor at CureScience. Marty previously worked at Cancer Commons and CollabRx. At CollabRx, they served as chairman from January 2008 to June 2012.

CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care.

For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients.

For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them.

For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward.

Marty Tenenbaum has a Ph.D. in Electrical Engineering and Computer Science from Stanford University as well as a BS and MS in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology.